Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Gheymati A"'
Autor:
Talasaz, Azita H., Sadeghipour, Parham, Kakavand, Hessam, Aghakouchakzadeh, Maryam, Kordzadeh-Kermani, Elaheh, Van Tassell, Benjamin W., Gheymati, Azin, Ariannejad, Hamid, Hosseini, Seyed Hossein, Jamalkhani, Sepehr, Sholzberg, Michelle, Monreal, Manuel, Jimenez, David, Piazza, Gregory, Parikh, Sahil A., Kirtane, Ajay J., Eikelboom, John W., Connors, Jean M., Hunt, Beverley J., Konstantinides, Stavros V., Cushman, Mary, Weitz, Jeffrey I., Stone, Gregg W., Krumholz, Harlan M., Lip, Gregory Y.H., Goldhaber, Samuel Z., Bikdeli, Behnood
Publikováno v:
In Journal of the American College of Cardiology 20 April 2021 77(15):1903-1921
Autor:
Vahid Eslami, Azin Gheymati
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3023-3026 (2020)
Abstract Liver damage is a rare side effect of clopidogrel. That is reversible in most cases. Considering the widespread use of this medication in cardiovascular diseases, the management of hepatotoxicity requires further meticulous investigation.
Externí odkaz:
https://doaj.org/article/cda8d9c701744e0b84331d57e42eb181
Autor:
Vahid Eslami, Azin Gheymati
Publikováno v:
Tehran University Medical Journal, Vol 78, Iss 8, Pp 547-552 (2020)
Background: Clopidogrel is an effective anti-platelet drug that is commonly prescribed for patients with atherosclerotic coronary and peripheral vascular diseases, especially after angioplasty and coronary artery bypass graft surgery. Even though thi
Externí odkaz:
https://doaj.org/article/9b97907a6ec8487ea54d8271b3aa596d
Autor:
Sevda mikailiMirak, Azita H. Talasaz, Yaser Jenab, Alireza Vatanara, Mohsen Amini, Arash Jalali, Azin Gheymati
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 32, Iss , Pp 100689- (2021)
Introduction: Radial approach for coronary angioplasty is accepted by many specialists in medical centers around the world. The use of radial access is associated with fewer vascular complications and the same success rate in comparison with traditio
Externí odkaz:
https://doaj.org/article/1cef5313949c48ec9c4cffadaf9a1478
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eslami, Vahid1 (AUTHOR), Gheymati, Azin2 (AUTHOR) gheimatiazin@gmail.com
Publikováno v:
Clinical Case Reports. Dec2020, Vol. 8 Issue 12, p3024-3027. 4p.
Publikováno v:
Anti-Cancer Drugs. 33:e1-e8
Pyoderma gangrenosum is a rare ulcerative dermatosis. It may be caused by some drugs, including small molecule tyrosine kinase inhibitors (TKIs). The aim of this study was to evaluate the reported evidence of pyoderma gangrenosum associated with the
Publikováno v:
Archives of Clinical Nephrology. :033-037
Background: Digoxin is a medication of Glycoside family which is commonly prescribed for patients with atrial fibrillation, atrial flutter, and heart failure. With a narrow therapeuticlevel(0.5–2 ng/mL), careful monitoring of digoxin blood level is
Autor:
Jeffrey I. Weitz, Seyed Hossein Hosseini, Gregory Piazza, David Jiménez, Gregory Y.H. Lip, Manuel Monreal, Sahil A. Parikh, Behnood Bikdeli, Mary Cushman, Ajay J. Kirtane, Michelle Sholzberg, Sepehr Jamalkhani, Parham Sadeghipour, Azita Hajhossein Talasaz, Azin Gheymati, Gregg W. Stone, Beverley J. Hunt, Harlan M. Krumholz, Maryam Aghakouchakzadeh, Benjamin W. Van Tassell, Samuel Z. Goldhaber, Hamid Ariannejad, Elaheh Kordzadeh-Kermani, Stavros Konstantinides, Jean M. Connors, Hessam Kakavand, John W. Eikelboom
Publikováno v:
Journal of the American College of Cardiology. 77:1903-1921
Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of C
Autor:
Seyed Hossein Hosseini, Azita H. Talasaz, Mohammad Alidoosti, Masih Tajdini, Benjamin W. Van Tassell, Nasrin Etesamifard, Hessam Kakavand, Arash Jalali, Maryam Aghakouchakzadeh, Azin Gheymati, Mohammad Sadeghian, Yaser Jenab
Publikováno v:
Journal of Cardiovascular Pharmacology.
Primary percutaneous coronary intervention (PPCI) is the gold standard of treatment in patients with acute ST-elevation myocardial infarction (STEMI). The no-reflow phenomenon (NRP) is a detrimental consequence of STEMI. Colchicine is an anti-inflamm